Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Co-carcinogenic effects of vitamin E in prostate.

Vivarelli F, Canistro D, Cirillo S, Papi A, Spisni E, Vornoli A, Croce CMD, Longo V, Franchi P, Filippi S, Lucarini M, Zanzi C, Rotondo F, Lorenzini A, Marchionni S, Paolini M.

Sci Rep. 2019 Aug 12;9(1):11636. doi: 10.1038/s41598-019-48213-1.

2.

Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians.

Storci G, De Carolis S, Papi A, Bacalini MG, Gensous N, Marasco E, Tesei A, Fabbri F, Arienti C, Zanoni M, Sarnelli A, Santi S, Olivieri F, Mensà E, Latini S, Ferracin M, Salvioli S, Garagnani P, Franceschi C, Bonafè M.

Cell Death Differ. 2019 Sep;26(9):1845-1858. doi: 10.1038/s41418-018-0255-8. Epub 2019 Jan 8.

PMID:
30622304
3.

Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.

Farabegoli F, Govoni M, Spisni E, Papi A.

Nutrients. 2018 Aug 22;10(9). pii: E1141. doi: 10.3390/nu10091141.

4.

EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.

Farabegoli F, Govoni M, Spisni E, Papi A.

Biosci Rep. 2017 May 17;37(3). pii: BSR20170168. doi: 10.1042/BSR20170168. Print 2017 Jun 30.

5.

Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein.

Romani P, Papi A, Ignesti M, Soccolini G, Hsu T, Gargiulo G, Spisni E, Cavaliere V.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1171-1182. Epub 2016 Jul 22.

PMID:
27449069
6.

Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue.

Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger FG, Pasquinelli G, Spisni E, Seracchioli R, Papi A.

Future Oncol. 2016 Jul;12(14):1699-711. doi: 10.2217/fon-2016-0032. Epub 2016 May 13.

PMID:
27173589
7.

Role of nuclear receptors in breast cancer stem cells.

Papi A, Orlandi M.

World J Stem Cells. 2016 Mar 26;8(3):62-72. doi: 10.4252/wjsc.v8.i3.62. Review.

8.

Carbonic Anhydrase 9 mRNA/microRNA34a Interplay in Hypoxic Human Mammospheres.

De Carolis S, Bertoni S, Nati M, D'Anello L, Papi A, Tesei A, Cricca M, Bonafé M.

J Cell Physiol. 2016 Jul;231(7):1534-41. doi: 10.1002/jcp.25245. Epub 2015 Nov 30.

PMID:
26553365
9.

Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.

Papi A, Govoni M, Ciavarella C, Spisni E, Orlandi M, Farabegoli F.

Curr Cancer Drug Targets. 2016;16(4):373-85.

PMID:
26278714
10.

A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.

Farabegoli F, Govoni M, Ciavarella C, Orlandi M, Papi A.

Biomed Res Int. 2014;2014:853086. doi: 10.1155/2014/853086. Epub 2014 Jun 11.

11.

PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche.

Papi A, De Carolis S, Bertoni S, Storci G, Sceberras V, Santini D, Ceccarelli C, Taffurelli M, Orlandi M, Bonafé M.

J Cell Physiol. 2014 Nov;229(11):1595-606. doi: 10.1002/jcp.24601.

PMID:
24604522
12.

Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.

Brandi G, Tavolari S, Guarnieri T, Di Marco M, Paterini P, Macchini M, Di Girolamo S, Papi A, De Rosa F, Biasco G.

Pancreas. 2014 Jan;43(1):53-63. doi: 10.1097/MPA.0b013e3182a6486e.

PMID:
24201777
13.

Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells.

Storci G, Bertoni S, De Carolis S, Papi A, Nati M, Ceccarelli C, Pirazzini C, Garagnani P, Ferrarini A, Buson G, Delledonne M, Fiorentino M, Capizzi E, Gruppioni E, Taffurelli M, Santini D, Franceschi C, Bandini G, Bonifazi F, Bonafé M.

Am J Pathol. 2013 Nov;183(5):1688-1697. doi: 10.1016/j.ajpath.2013.07.020. Epub 2013 Sep 12.

PMID:
24036252
14.

Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells.

Papi A, Farabegoli F, Iori R, Orlandi M, De Nicola GR, Bagatta M, Angelino D, Gennari L, Ninfali P.

Food Chem. 2013 Jun 1;138(2-3):1521-30. doi: 10.1016/j.foodchem.2012.11.112. Epub 2012 Dec 5.

PMID:
23411276
15.

Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.

Papi A, Storci G, Guarnieri T, De Carolis S, Bertoni S, Avenia N, Sanguinetti A, Sidoni A, Santini D, Ceccarelli C, Taffurelli M, Orlandi M, Bonafé M.

PLoS One. 2013;8(1):e54968. doi: 10.1371/journal.pone.0054968. Epub 2013 Jan 25.

16.

Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon.

Valerii MC, Benaglia M, Caggiano C, Papi A, Strillacci A, Lazzarini G, Campieri M, Gionchetti P, Rizzello F, Spisni E.

Nanomedicine. 2013 Jul;9(5):675-85. doi: 10.1016/j.nano.2012.11.007. Epub 2012 Dec 6.

PMID:
23219878
17.

Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells.

Dozza B, Papi A, Lucarelli E, Scotlandi K, Pierini M, Tresca G, Donati D, Orlandi M.

Toxicol In Vitro. 2012 Feb;26(1):142-9. doi: 10.1016/j.tiv.2011.10.009. Epub 2011 Oct 25.

PMID:
22056261
18.

RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.

Papi A, Rocchi P, Ferreri AM, Orlandi M.

Cancer Lett. 2010 Nov 1;297(1):65-74. doi: 10.1016/j.canlet.2010.04.026. Epub 2010 May 26.

PMID:
20510503
19.

(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.

Farabegoli F, Papi A, Orlandi M.

Biosci Rep. 2011 Apr;31(2):99-108. doi: 10.1042/BSR20090143.

PMID:
20446926
20.

Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.

Papi A, Ferreri AM, Rocchi P, Guerra F, Orlandi M.

Anticancer Res. 2010 Feb;30(2):535-40.

PMID:
20332466

Supplemental Content

Loading ...
Support Center